Wednesday 28 September 2022 10:47 PM Scientists' joy as decades-long hunt for Alzheimer's drug finally bears fruit trends now
Wednesday 28 September 2022 10:47 PM Scientists' joy as decades-long hunt for Alzheimer's drug finally bears fruit trends now
Scientists' joy as decades-long hunt for Alzheimer's drug finally bears fruit Lecanemab as proven it can slow cognitive decline and tackle the underlying cause of Alzheimer’s. Until now none has succeeded in the dual aim n pursuit of a breakthrough drug Results show those given the drug experienced a less rapid decline in memory
Drugs firms have spent decades and billions of pounds in pursuit of a breakthrough drug for Alzheimer’s.
Until now none has succeeded in the dual aim of slowing cognitive decline and tackling what is believed to be the underlying cause.
Lecanemab has sparked excitement because it is the first to prove in clinical trials that it can do both. It works by flushing out harmful amyloid toxins, which form into plaques in the brain where they kill cells and
